Bionano Genomics, Inc.
Company Information
Industry Laboratory Analytical Instruments
SIC Code 3826
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA, 92121
Mailing Address 9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA, 92121
Phone (858) 888-7600
Fiscal Year End 1231
EIN 261756290
Financial Overview
FY2025
$-4.85
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 23, 2026 | View on SEC |
| 10-K Annual financial report | March 23, 2026 | View on SEC |
| 4 Insider stock transaction report | February 18, 2026 | View on SEC |
| 4 Insider stock transaction report | February 18, 2026 | View on SEC |
| 4 Insider stock transaction report | February 18, 2026 | View on SEC |
| 4 Insider stock transaction report | February 18, 2026 | View on SEC |
| 4 Insider stock transaction report | February 18, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| 4 Insider stock transaction report | February 4, 2026 | View on SEC |
Annual Reports
10-K March 23, 2026
- Successful fundraising in 2024 and early 2025 through convertible notes and stock sales, ensuring liquidity.
- Proactive debt management, including a significant debt-for-equity swap in June 2024 to reduce debt and manage dilution.
Material Events
8-K Financial Distress March 23, 2026
High Impact
- Aggressive 55% annual cost reduction significantly improved gross profit margin to 46%.
- 47% payment rate increase for OGM in hematologic malignancies boosts future revenue potential.
Related Companies
Companies in the same industry (SIC: 3826)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.